Can Serum Glypican-3 Be a Biomarker for Effective Diagnosis of Hepatocellular Carcinoma? A Meta-Analysis of the Literature

<div>Forest plots of sensitivity and specificity of using GPC3 as a diagnostic marker for hepatocellular cancer (HCC) in the eighteen studies included for meta-analysis [<a href="/journals/dm/2014/127831/#B10">10</a>–<a href="/journals/dm/2014/127831/#B27">27</a>].</div>

Disease Markers

fig3

Figure 3

Figure 3: Can Serum Glypican-3 Be a Biomarker for Effective Diagnosis of Hepatocellular Carcinoma? A Meta-Analysis of the Literature 